Canada markets closed

Certara, Inc. (CERT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.95-0.09 (-0.64%)
At close: 04:00PM EDT
14.50 +0.55 (+3.94%)
After hours: 07:25PM EDT

Certara, Inc.

100 Overlook Center
Suite 101
Princeton, NJ 08540
United States
609 716 7900
https://www.certara.com

Sector(s)Healthcare
IndustryHealth Information Services
Full Time Employees1,054

Key Executives

NameTitlePayExercisedYear Born
Dr. William F. Feehery Ph.D.CEO & Director1.24MN/A1971
Mr. M. Andrew SchemickChief Financial Officer568.7kN/A1974
Mr. Leif E. PedersenPres of Software434.11kN/A1964
Dr. Robert P. Aspbury Ph.D.Pres of Simcyp Division541.23kN/A1972
Mr. Andrew SchemickChief Financial OfficerN/AN/AN/A
Prof. Amin Rostami PharmD, Ph.D., FCPChief Scientific OfficerN/AN/AN/A
Mr. Richard M. TraynorSr. VP, Gen. Counsel & Sec.N/AN/A1972
Ms. Jieun W. ChoeChief Strategy & Marketing OfficerN/AN/A1975
Mr. Ron DiSantisSr. VP of Corp. Devel.N/AN/AN/A
Ms. Nicolette D. ShermanChief HR OfficerN/AN/A1970
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Corporate Governance

Certara, Inc.’s ISS Governance QualityScore as of October 1, 2022 is 7. The pillar scores are Audit: 9; Board: 6; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.